XLRN
Acceleron Pharma Inc
Price:  
178.75 
USD
Volume:  
7,201,419.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Acceleron EV/EBITDA

-132.3%
Upside

As of 2024-03-05, the EV/EBITDA ratio of Acceleron Pharma Inc (XLRN) is -41.25. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Acceleron's latest enterprise value is 10,456.47 mil USD. Acceleron's TTM EBITDA according to its financial statements is -253.46 mil USD. Dividing these 2 quantities gives us the above Acceleron EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 12.6x - 13.7x 12.8x
Forward P/E multiples 16.7x - 17.6x 17.4x
Fair Price (64.45) - (51.85) (57.81)
Upside -136.1% - -129.0% -132.3%
178.75 USD
Stock Price
(57.81) USD
Fair Price

Acceleron EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA